Franklin Genomic Advancements
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HELX and other ETFs, options, and stocks.About HELX
HELX is an actively managed portfolio of global equity securities of companies relevant to genomic discovery. The listed name for HELX is Franklin Genomic Advancements ETF.
CategoryHealth
CategoryHealth
Number of holdings67
Number of holdings67
Inception DateFeb 25, 2020
Inception DateFeb 25, 2020
What's in this fund
Sectors
As of January 12, 2026Healthcare97.33%
Basic Materials1.94%
Technology0.73%
HELX Key Statistics
AUM22.40M
AUM22.40M
Price-Earnings ratio-926.25
Price-Earnings ratio-926.25
30-Day yield—
30-Day yield—
Average volume2.78K
Average volume2.78K
High today$37.34
High today$37.34
Low today$37.00
Low today$37.00
Open price$37.00
Open price$37.00
Volume1.22K
Volume1.22K
52 Week high$38.17
52 Week high$38.17
52 Week low$23.74
52 Week low$23.74
Expense ratio0.50
Expense ratio0.50
Stock Snapshot
As of today, Franklin Genomic Advancements(HELX) shares are valued at $37.34. The company's market cap stands at 22.37M, with a P/E ratio of -926.25 and a dividend yield of 11.3%.
During the trading session on 2026-01-14, Franklin Genomic Advancements(HELX) shares reached a daily high of $37.34 and a low of $37.00. At a current price of $37.34, the stock is +0.9% higher than the low and still 0.0% under the high.
Trading volume for Franklin Genomic Advancements(HELX) stock has reached 1.22K, versus its average volume of 2.78K.
The stock's 52-week range extends from a low of $23.74 to a high of $38.17.
The stock's 52-week range extends from a low of $23.74 to a high of $38.17.